On the HCPLive gout page, resources on the topics of medical news and expert insight into gouty arthritis can be found. Content includes articles, interviews, videos, podcasts, and breaking news on gout, and more.
June 13th 2024
Findings highlight an urgent need for improved gout management strategies to reduce costs, improve quality of life, and reduce gout symptoms in patients with comorbid gout and CKD.
Endocrine Case Report: Thumb Swelling and Redness
May 1st 2023Our latest case report from Brady Pregerson, MD, featuresa woman in her mid-60s with a history of Hashimoto’s thyroiditis treated with levothyroxine presenting to the hospital with 4-5 days of pain, swelling and redness on her left thumb.
Lumbar Bone Mineral Density Negatively Linked to Hyperuricemia in Obesity
A negative relationship between bone mineral density (BMD) and hyperuricemia in total, as well as in the L1, L2, and L3 lumbar vertebrae, was demonstrated in the multivariable-adjusted regression models.
A Potential New Role for Colchicine: Unraveling Inflammation in ASCVD
April 7th 2023The evolving recognition of inflammation as a driver of cardiovaacular risk and has led some to speculate around a potential role for colchicine 0.5 mg, which has a PDUFA date in June 2023, for reducing risk in patients with ASCVD.
Phase 3 DISSOLVE Trials Prove SEL-212's Urate-Lowering Ability in Chronic Gout
March 21st 2023An announcement from Selecta Biosciences and Sobi provide the latest update on DISSOLVE clinical program, with new data indicating SEL-212 met the primary endpoint of achieving serum urate control during month 6.
Temporary Increase in Venous Thromboembolism Observed After Gout Flare
A brief increase in venous thromboembolism (VTE) was reported within 30 days after a hospitalization or primary care visit for gout flare. The highest incidence occurred during the 16-30 day period after the flare.
Quality of Life Less Impacted by Gout than Other Inflammatory Joint Diseases
February 9th 2023An analysis of survey data from more than 2000 patients in Western Sweden is providing insight into how the impact of inflammatory joint disease on health-related quality of life differs among those with gout, RA, PsA, and ankylosing spondylitis.